☆ 4.4 Article

Diagnosis and management of rhinosinusitis: a practice parameter update

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)

Get Full Text
Add to Collection

Journal

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
Volume 113, Issue 4, Pages 347-385

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.anai.2014.07.025

Keywords

-

Categories

Allergy Immunology

Funding

  1. AstraZeneca
  2. GSK
  3. Merck
  4. Novartis
  5. BI
  6. Genentech
  7. TEVA
  8. Sanofi Aventis
  9. Amgen
  10. Cephalon
  11. Johnson Johnson
  12. Cytos

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.